China Slaps $50B LAWSUIT on U.S. Senator

Seal of the United States Senate featuring an eagle and stars

A Chinese court just put a $50 billion price tag on an American state’s free speech, and one U.S. senator is turning that threat into a public referendum on China, sovereignty, and common sense accountability.

Story Snapshot

Wuhan’s city government and top Chinese science institutions are suing Missouri and Sen. Eric Schmitt for roughly $50 billion over COVID-era accusations.
The Chinese lawsuit mirrors Schmitt’s 2020 case against China, turning pandemic blame into cross-border “lawfare.”
Schmitt calls the case pure retaliation and says he “won’t be apologizing” for challenging Beijing’s COVID narrative.
The fight exposes a deeper clash over who gets to tell the truth about COVID—and whether U.S. officials should fear foreign courts.

How a State-Level Lawsuit Turned Missouri Into China’s $50 Billion Target

Missouri’s clash with China began in April 2020, when then–Attorney General Eric Schmitt sued the People’s Republic of China, the Chinese Communist Party, several ministries, Hubei Province, and related entities over COVID-19 harms to Missourians. The case argued that Chinese authorities mismanaged the outbreak, suppressed critical information, and unleashed massive health and economic damage on the state. Legal experts warned from the start that foreign sovereign immunity made the suit mostly symbolic, but symbol and signal were exactly the point.

Sen Eric Schmitt says he ‘won’t be apologizing’ as China hits him with $50B lawsuit https://t.co/s4iXqrQQTv

— News Span Media (@newsspanmedia) December 17, 2025

Schmitt’s lawsuit named institutions tied closely to Wuhan, including entities now suing him in return, and it fed into a broader American demand for answers on COVID’s origins and early cover-up claims. While no one expected China to show up in a U.S. courtroom with a checkbook, the filing told voters that Missouri’s top lawyer would confront Beijing rather than shrug off the pandemic as an unavoidable act of nature. That tough-on-China stance later became a key plank in Schmitt’s successful 2022 U.S. Senate campaign.

China Strikes Back: Wuhan, CAS, and WIV Go to Court

The response arrived on China’s home turf: the municipal government of Wuhan, the Chinese Academy of Sciences (CAS), and the Wuhan Institute of Virology (WIV) filed a civil lawsuit in the Wuhan Intermediate People’s Court seeking around US$50 billion. Their complaint names the State of Missouri, Governor Mike Kehoe, Sen. Eric Schmitt, former Missouri Attorney General Andrew Bailey, and others as defendants. The plaintiffs claim that Missouri’s suit and public statements “politicised” the pandemic, smeared China, and inflicted vast reputational and economic damage.

Chinese filings portray Wuhan, CAS, and WIV as victims of slander who suffered lost collaborations, funding, and international standing because American officials pushed lab-leak, cover-up, and PPE-hoarding narratives. The case dovetails with Beijing’s long-running message that Western criticism of its COVID response is a bad-faith campaign to stigmatize China. From a conservative American perspective, the striking piece is not that China objects, that was expected, but that state-linked institutions now claim the right to financially punish a U.S. state and its officials for speech and litigation conducted inside the United States.

THE CHINESE HAVE STOLEN FROM THE US FOR DECADES. LETS COUNTER SUE IF THATS EVEN POSSIBLE. THEY ARE QUITE POSSIBLY FUELING THE DRUG CARTELS TOO. WHAT ABOUT THAT? Sen Eric Schmitt says he ‘won’t be apologizing’ as China hits him with $50B lawsuithttps://t.co/JDfNrtPEOq

— Dori Girl (@DoriGirl13) December 17, 2025

Lawfare Without Teeth: Symbolic Judgments and Real Politics

Both Missouri’s 2020 lawsuit and China’s new response face the same blunt reality: their judgments are almost certainly unenforceable on the other side’s soil. U.S. courts shield foreign governments with sovereign immunity; Chinese courts issue rulings that American states are under no obligation to recognize. Yet neither side is really chasing a collectible judgment. Each uses its own courts as a stage to tell a political story: Missouri’s complaint framed China as responsible for extraordinary harm to ordinary Americans. At the same time, Wuhan’s suit recasts Missouri as an “economic and reputational menace.”

From a rule-of-law standpoint, the asymmetry matters. Missouri filed in a U.S. federal court constrained by open procedure and substantive doctrines such as sovereign immunity, even when politically inconvenient. Wuhan’s case unfolds in a system where courts operate under Communist Party oversight, and where reputational and “anti-stigmatization” suits increasingly serve as diplomatic tools. Calling both “lawfare” is accurate; equating their legal environments is not. For voters who value constitutional protections and state sovereignty, that difference goes to the heart of which side is more trustworthy in any dispute over facts.

Schmitt’s Response: No Apology, and a Warning Shot About Intimidation

Sen. Schmitt has not treated the lawsuit as a nudge toward moderation. He calls the case baseless retaliation and says he “won’t be apologizing,” arguing that the sheer scale of the demand shows his original lawsuit “hit a nerve” with Beijing. On Fox News’ “The Ingraham Angle,” he framed the action as a pressure campaign to deter U.S. officials from challenging China on COVID or anything else. That framing aligns closely with a conservative instinct: you do not reward authoritarian overreach by backing down.

Schmitt’s stance resonates with Americans who see a dangerous precedent in allowing foreign regimes to price-tag U.S. political speech. If a Chinese court can declare Missouri liable for $50 billion today, nothing stops similar rulings against other states, governors, or federal officials tomorrow. According to Missouri Attorney General–linked materials, China effectively branded the state an “economic and reputational menace,” a label that reads more like propaganda than a legal conclusion. That helps Schmitt argue this fight is bigger than one senator’s rhetoric.

What This Clash Reveals About U.S.–China Tensions and Common Sense

The dueling lawsuits expose more than bruised egos; they underline a hardening divide between a constitutional republic and a one-party state over who controls the story of COVID-19. Missouri’s action, whatever its legal odds, reflected a basic American expectation: when government failures abroad help devastate your citizens’ lives and livelihoods, you at least try to seek accountability. Wuhan’s suit instead demands that criticism itself carry a financial penalty, even when voiced by elected officials speaking to their own constituents.

From a common-sense, conservative viewpoint, the Chinese case reinforces long-standing concerns. A system that censors domestic dissent now extends its reach outward, using its courts to chill unwelcome speech overseas. American officials cannot afford to normalize that pattern. Cross-border research and trade matter, but they do not justify importing foreign speech controls by the back door of unenforceable judgments. However this $50 billion drama ends on paper, the practical question for readers is simple: do you want your leaders apologizing to Beijing for asking hard questions, or doubling down until those questions get real answers?